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The Glymphatic System: A New Player in
Ocular Diseases?
In June 2015, Denniston and Keane1 and our group2
independently hypothesized the existence of a paravascular
transport system in the retina and the optic nerve, respectively,
analogous to the described glymphatic system in the brain.
Recent research is now providing more substantial evidence for
a glymphatic system in the eye.
The glymphatic system was first described by Iliff et al.3 in
2012. The authors defined for the first time a brain-wide
network of paravascular channels in mice, which they called
the ‘‘glymphatic’’ pathway, along which a large proportion of
subarachnoid cerebrospinal fluid (CSF) recirculates through the
brain parenchyma, facilitating the clearance of interstitial
solutes, including amyloid-b (Ab), from the brain.3 This brain-
wide anatomical pathway consists of three elements: a para-
arterial CSF influx route, a paravenous interstitial fluid (ISF)
clearance route, and a transparenchymal pathway that is
dependent upon astroglial water transport via the astrocytic
aquaporin-4 (AQP4) water channel.4 One implication of these
findings is that glymphatic pathway dysfunction may contribute
to the deficient Ab clearance in Alzheimer’s disease.5
Denniston and Keane1 proposed that a similar glymphatic
system, or at least a paravascular system, is present in the
retina, and that this may be a key player in retinal diseases
ranging from age-related macular degeneration to retinal
vasculitis. Their hypothesis was originally based on extrapola-
tion of the findings in the brain to the retina, but the authors
also discussed evidence from adaptive optics imaging studies of
patients with retinal vasculitis to support their theory.1
In our 2015 paper, we reviewed several lines of evidence
suggesting that the glymphatic system may also have potential
clinical relevance for the understanding of the pathophysiology
of glaucoma.2 Since the optic nerve is a white matter tract of
the central nervous system that extends into the orbit where it
is surrounded by CSF in the subarachnoid space,2 an intriguing
question is whether there is also evidence for the existence of a
paravascular transport system within the optic nerve. In light of
the key role that the glymphatic pathway may play in the
clearance of interstitial solutes from the brain, the observation
of such an anatomically distinct clearing system in the optic
nerve could be of great importance for our understanding of
how solutes are cleared from the ISF in the optic nerve, and
could provide new insights into the pathogenesis of glaucoma.
Indeed, if confirmed, one might expect that a dysfunctional
glymphatic system could ultimately result in reduced neuro-
toxin clearance in the optic nerve leading to glaucomatous
optic neuropathy.2
In a postmortem study to investigate the possibility of a
paravascular fluid circulation, or at least paravascular spaces, in
the human optic nerve, we examined cross-sections of human
optic nerves by light microscopy after administering India ink
by bolus injection into the subarachnoid space of the optic
nerve (work in progress). The results demonstrated accumula-
tion of India ink in paravascular spaces around the central
retinal artery and vein, whereas the lumens of these vessels
remained unlabeled. The deposits were located between
collagen fiber bundles lining a slit-like space (Fig.).
In addition, in their report presented at this year’s ARVO
Annual Meeting, Hu and colleagues (Hu P, et al. IOVS
2016;57:ARVO E-Abstract 996) provided evidence for a
glymphatic system in human, primate, rat, and mouse retina.
Retinas were examined using multimarker immunohistochem-
istry. A glial network of AQP4þ ensheathed the entire retinal
vascular system, including between blood vessels, and the
authors concluded that this may be the anatomical correlate of
a retinal glymphatic system.
Given the evidence for a glymphatic system in human retina,
and given that our postmortem study demonstrated para-
vascular spaces around the central retinal artery and vein in the
human optic nerve, it would be interesting to further
investigate whether a ‘‘paravascular communication’’ exists
between the surroundings of the retinal vascular system and
the surroundings of the central retinal vessels in the optic
nerve. On the basis of magnetic resonance imaging findings of
Terson’s syndrome and their review of the literature, Sakamoto
et al.6 speculated that the branches of the central retinal vessels
in the retina are probably also surrounded by paravascular
spaces and that they may serve as drainage channels from the
subarachnoid space around the optic nerve to beneath the
internal limiting membrane forming the boundary of the retina
with the vitreous body. Importantly, Ab has been reported to
increase by chronic elevation of intraocular pressure (IOP) in
animals with experimentally induced ocular hypertension and
to cause retinal ganglion cell death.7–10 At least theoretically,
such a paravascular, ‘‘retino-orbital’’ continuity could facilitate
elimination of neurotoxins, such as Ab, induced by high IOP.
Demonstration of such a clearance system would support our
hypothesis that glaucoma, just like Alzheimer’s disease, may
occur when there is an imbalance between production and
clearance of neurotoxins.2,11 In normal-tension glaucoma,
reduced clearance of Ab might predominate as a result of
glymphatic pathway dysfunction.2 In high-tension glaucoma,
IOP-induced Ab generation might predominate and even mild
impairment of glymphatic pathway function might result in
glaucomatous optic nerve damage.2
Interestingly, a growing body of evidence indicates that
intracranial pressure (ICP) is lower in patients with primary
open-angle glaucoma (POAG) when compared with nonglau-
comatous control subjects.12 In addition, ICP was reported to be
lower in the normal-tension compared with the high-tension
form of POAG.12 If the ICP is too low, fluid flow from the
paravascular spaces in the optic nerve to the paravascular
spaces in the retina may decline or stop, given that this
paravascular flow must cross the trans-lamina cribrosa pressure
barrier (IOP-ICP). Normally, IOP is higher than ICP.12 An increase
FIGURE. Cross-section through the optic nerve: distribution of ink in
the surroundings of the central retinal artery showing the complex slit-
like space (Holmes-Luxol, ·400).
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in IOP, a decrease in ICP or a decrease in the thickness of the
lamina cribrosa may increase the pressure barrier against which
paravascular flow from the optic nerve to the retina needs to
occur. Patients with low ICP and high trans-lamina cribrosa
pressure barriers may therefore be more likely to develop
suppression of glymphatic fluid transport leading to reduced Ab
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